Patent details

EP3139930 Title: SALTS AND POLYMORPHS OF CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF

Basic Information

Publication number:
EP3139930
PCT Application Number:
US2015028265
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP157886581
PCT Publication Number:
WO2015171398
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SALTS AND POLYMORPHS OF CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF
French Title of Invention:
SELS ET POLYMORPHES DE DÉRIVÉS CYCLIQUES D'ESTER D'ACIDE BORONIQUE, ET LEURS UTILISATIONS THÉRAPEUTIQUES
German Title of Invention:
SALZE UND POLYMORPHE VON CYCLISCHEN BORSÄUREESTERDERIVATEN UND THERAPEUTISCHE VERWENDUNGEN DAVON
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
13/09/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
01/10/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
14/08/2024
Unitary Effect Registration Date:
01/10/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
29/04/2015
Grant date:
14/08/2024
EP Publication Date:
15/03/2017
PCT Publication Date:
12/11/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/08/2024
EP B1 Publication Date:
14/08/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/08/2024
 
 

Name:
Melinta Therapeutics, Inc.
Address:
389 Interpace Parkway, Suite 450, Parsippany, NJ 07054, United States (US)

Inventor

1

Name:
CHEN, Pingyun
Address:
United States (US)

2

Name:
KUSALAKUMARI SUKUMAR, Senthil Kumar
Address:
United States (US)

3

Name:
BIS, Joanna A.
Address:
United States (US)

Priority

Priority Number:
201461988524 P
Priority Date:
05/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/397; A61K 31/545; A61K 31/69; A61P 31/04; A61P 31/10; C07F 5/02;

Publication

European Patent Bulletin

1

Issue number:
202433
Publication date:
14/08/2024
Description:
Grant (B1)

2

Issue number:
202443
Publication date:
23/10/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202444
Publication date:
30/10/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages